CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-06 | Pierce Robert Hamilton Chief Scientific Officer | Sale | −6,460 | $7.11 | $46K | 89,362 |
| 2021-07-30 | Humer Kristian Director | Grant or award · Stock Option (Right to Buy) | +16,667 | 16,667 | ||
| 2021-05-05 | Cambrian BioPharma Inc 10% owner | Purchase | +350 | $12.00 | $4K | 4,812,244 |
| 2021-05-05 | Peyer James Director | Purchase | +350 | $12.00 | $4K | 4,812,244 |
| 2021-04-20 | Cambrian BioPharma Inc 10% owner | Purchase | +385 | $12.77 | $5K | 4,811,894 |
| 2021-04-20 | Peyer James Director | Purchase | +385 | $12.77 | $5K | 4,811,894 |
| 2021-04-19 | Peyer James Director | Purchase | +1,965 | $13.38 | $26K | 4,811,509 |
| 2021-04-19 | Cambrian BioPharma Inc 10% owner | Purchase | +1,965 | $13.38 | $26K | 4,811,509 |
| 2021-04-13 | Cambrian BioPharma Inc 10% owner | Purchase | +2,000 | $14.00 | $28K | 4,809,544 |
| 2021-04-13 | Peyer James Director | Purchase | +2,000 | $14.00 | $28K | 4,809,544 |
| 2021-04-07 | Peyer James Director | Purchase | +2,000 | $14.00 | $28K | 4,807,544 |
| 2021-04-07 | Cambrian BioPharma Inc 10% owner | Purchase | +2,000 | $14.00 | $28K | 4,807,544 |
| 2021-04-01 | English Jessie Director | Grant or award · Stock Option (Right to Buy) | +16,667 | 16,667 | ||
| 2021-04-01 | Cambrian BioPharma Inc 10% owner | Purchase | +1,000 | $14.00 | $14K | 4,805,544 |
| 2021-04-01 | Peyer James Director | Purchase | +1,000 | $14.00 | $14K | 4,805,544 |
| 2021-03-30 | Cambrian BioPharma Inc 10% owner | Purchase | +2,000 | $12.00 | $24K | 4,804,544 |
| 2021-03-30 | Peyer James Director | Purchase | +2,000 | $12.00 | $24K | 4,804,544 |
| 2021-03-24 | Peyer James Director | Purchase | +3,750 | $14.12 | $53K | 4,802,544 |
| 2021-03-24 | Cambrian BioPharma Inc 10% owner | Purchase | +3,750 | $14.12 | $53K | 4,802,544 |
| 2021-03-23 | Peyer James Director | Purchase | +9,500 | $14.34 | $136K | 4,798,293 |
Page 17 of 20 · 385 trades